CT based radiomic approach on first line pembrolizumab in lung cancer

CT based radiomic approach on first line pembrolizumab in lung cancer

Abstract Clinical evaluation poorly predicts outcomes in lung cancer treated with immunotherapy. The aim of the study is to assess whether CT-derived texture parameters can predict overall survival (OS) and progression-free survival (PFS) in patients with advanced non-small-cell lung cancer (NSCLC)...

Full description

Bibliographic Details
Main Authors: Marta Zerunian, Damiano Caruso, Alberto Zucchelli, Michela Polici, Carlo Capalbo, Marco Filetti, Federica Mazzuca, Paolo Marchetti, Andrea Laghi
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-86113-5

Internet

https://doi.org/10.1038/s41598-021-86113-5

Similar Items